Profile of ipilimumab and its role in the treatment of metastatic melanoma
Sapna P Patel, Scott E WoodmanMelanoma Medical Oncology Department, University of Texas, MD Anderson Cancer Center, Houston, TX, USAAbstract: Melanoma is an immunogenic cancer. However, the ability of the immune system to eradicate melanoma tumors is affected by intrinsic negative regulatory mechani...
Main Authors: | Patel SP, Woodman SE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-12-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/profile-of-ipilimumab-and-its-role-in-the-treatment-of-metastatic-mela-a8882 |
Similar Items
-
IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01) -
Ipilimumab in the treatment of metastatic melanoma: management of adverse events
by: Della Vittoria Scarpati G, et al.
Published: (2014-02-01) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
by: Joanne M. Jeter, et al.
Published: (2012-07-01) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
by: Joanne M. Jeter, et al.
Published: (2012-01-01) -
Ipilimumab cystic hypophysitis mimicking metastatic melanoma
by: John Wallace, BS, et al.
Published: (2018-06-01)